Bioethics in biotechnology: From pain to gain

Drug Development Research

Volumn 63, Issue 3, 2004, Pages 93-102

  Dhanda, Rahul K ^a,b,c  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b YALE UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

Bioethics; Biotechnology; Ethics

Indexed keywords

BIOTECHNOLOGY; DECISION MAKING; DRUG INDUSTRY; ETHICS; MORALITY; REVIEW;

EID: 16344364737     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10409     Document Type: Review

References (16)

1. Caulfield T. 2000. Underwhelmed: hyperbole, regulatory policy and the genetic revolution. McGill Law J 45:437-460.
2. Dhanda RK. 2002. Guiding Icarus: merging bioethics with corporate interests. New York: Wiley-Liss. 296 p.
3. DuBois W. 2003. New drug research, the extraterritorial application of FDA regulations, and the need for international cooperation. Vanderbilt J Transna Law 36:161-207.
4. Habermas, J. 1985. The theory of communicative action, volume 1. Boston, MA: Beacon Press. 399 p.
5. Grunfeld E, Zizeisberger L, Coristine M, Aspelund F. 2002. Barriers and facilitators to enrollment in cancer clinical trials. Cancer 95:1577-1583.
6. MacDonald C. 2003. Patents and benefit-sharing as a challenge for corporate ethics. In: Knoppers BM, editor Populations and genetics: legal and socio-ethical perspectives. Leiden/Boston: Martinus Nijhoff Publishers. p 505-523.
7. MacDonald C. 2004a. Stakeholder analysis for the biotech industry. Annual Meeting of the Society for Business Ethics, Seattle, August 2004.
8. MacDonald C. 2004b. Business Ethics 101 for the Biotech Industry. BioDrugs 18:71-77.
9. MacDonald C, Dhanda RK. 2003. Ethics in biotechnology: an executive guide. Version 1.0. (Available at http://www.biotechethics.ca/).
10. Paine LS. 2003. Value shift: why companies must merge social and financial imperatives to achieve superior performance. New York. McGraw-Hill. 304 p.
11. Reichheld FF, Teal T. 1996. The loyalty effect: The hidden force behind growth, profits, and lasting value. Boston, MA: Harvard Business School Press. 323 p.
12. Scott A. 2003. No lifting of Euro GM ban, yet. The Scientist Daily News (December 11). (Available at http://www.biomedcentral. com/news/20031211/03).
13. SIA & Semiconductor Industry History (Available at www. semichips.org/abt_history.cfm).
14. Verfaille HA. 2003. Monsanto chief executive outlines commitments on new agricultural technologies in the "New Monsanto Pledge." (Available at http://www.monsanto.com/monsanto/layout/media/ 00/11-27-00.asp).
15. Vogel G. 2003. Stem cells lose market luster. Science 299:1830-1831.
16. Wittgenstein L. 2001. Tractatus Logico-Philosophicus. London: Routledge. 128 p.